Trial Profile
A retrospective study to evaluate the re-irradiation and bevacizumab in patients with recurrent high-grade glioma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 11 Dec 2015 New trial record